Literature DB >> 24999747

Conformational investigation in solution of a fluorinated anti-inflammatory drug by NMR spectroscopy in weakly ordering media.

Maria Enrica Di Pietro1, Christie Aroulanda, Denis Merlet, Giorgio Celebre, Giuseppina De Luca.   

Abstract

The structural and conformational elucidation of flexible bioactive molecules in solution is currently a crucial goal for the scientific community, but it is rarely achievable by available techniques. The anti-inflammatory drug diflunisal is presented here as a model case for supporting the efficiency of NMR spectroscopy combined with the use of weakly ordering media as a promising methodology for the conformational investigation of small bioactive molecules. Starting from NMR anisotropic data (40 independent dipolar couplings), a quite accurate description of its torsional distribution around the inter-ring C-C bond was found, characterized by a pair of two couples of conformers. According to the relative configuration of the carboxylic group and the fluorine atom in the ortho position to the inter-ring C-C bond, the more stable couple of conformers are defined as "trans" type conformers (F opposite to the carboxylic group) whereas the less stable couple are "cis" type conformers (F and carboxylic group on the same side). In order to study the influence of fluorine nuclei on the structure and conformational distribution, the same analytical strategy has been applied to investigate the phenylsalicylic acid, its nonfluorinated analogue.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24999747     DOI: 10.1021/jp505084g

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  1 in total

1.  Determination of Configuration and Conformation of a Reserpine Derivative with Seven Stereogenic Centers Using Molecular Dynamics with RDC-Derived Tensorial Constraints*.

Authors:  Emine Sager; Pavleta Tzvetkova; Alvar D Gossert; Philippe Piechon; Burkhard Luy
Journal:  Chemistry       Date:  2020-10-01       Impact factor: 5.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.